Calton & Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,826
| Closed | -$208K | – | 305 |
|
2022
Q4 | $208K | Buy |
+1,826
| New | +$208K | 0.08% | 255 |
|
2022
Q2 | – | Sell |
-2,243
| Closed | -$236K | – | 369 |
|
2022
Q1 | $236K | Sell |
2,243
-1,329
| -37% | -$140K | 0.07% | 299 |
|
2021
Q4 | $384K | Sell |
3,572
-72
| -2% | -$7.74K | 0.1% | 216 |
|
2021
Q3 | $399K | Sell |
3,644
-30
| -0.8% | -$3.29K | 0.09% | 232 |
|
2021
Q2 | $344K | Sell |
3,674
-120
| -3% | -$11.2K | 0.07% | 268 |
|
2021
Q1 | $349K | Buy |
+3,794
| New | +$349K | 0.07% | 246 |
|
2020
Q4 | – | Sell |
-2,912
| Closed | -$226K | – | 403 |
|
2020
Q3 | $226K | Sell |
2,912
-2,217
| -43% | -$172K | 0.05% | 293 |
|
2020
Q2 | $285K | Buy |
+5,129
| New | +$285K | 0.06% | 234 |
|
2020
Q1 | – | Sell |
-8,711
| Closed | -$315K | – | 394 |
|
2019
Q4 | $315K | Buy |
8,711
+177
| +2% | +$6.4K | 0.06% | 248 |
|
2019
Q3 | $232K | Buy |
+8,534
| New | +$232K | 0.05% | 287 |
|